CME
CME Group Inc.
Stock
$263.14−1.96 (−0.74%)Close Oct 2, 2026
- EBITDA, 2025
- $4.3B
- YoY, 2025
- +7.2%
- 5-year CAGR
- +9.2%
- 10-year CAGR
- +7.4%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $4.3B | +7.2% |
| 2024 | $4.0B | +13.6% |
| 2023 | $3.6B | +13.0% |
| 2022 | $3.2B | +12.8% |
| 2021 | $2.8B | +0.1% |
| 2020 | $2.8B | +1.6% |
| 2019 | $2.7B | +0.7% |
| 2018 | $2.7B | +12.5% |
| 2017 | $2.4B | +4.0% |
| 2016 | $2.3B | +10.0% |
| 2015 | $2.1B | +11.4% |
| 2014 | $1.9B | +7.3% |
| 2013 | $1.8B | −3.1% |
| 2012 | $1.8B | −14.9% |
| 2011 | $2.1B | +9.6% |
| 2010 | $2.0B | +14.3% |
| 2009 | $1.7B | −0.2% |
| 2008 | $1.7B | +48.5% |
| 2007 | $1.2B | — |